Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Circulation. Cardiovascular Quality and Outcomes

• Publication date

  2009-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCOUTCOMES.108.807123PMID 20031808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness in health and medicine

  2016cited by this paper
• Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

  2008cited by this paper
• Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.

  2007cited by this paper
• Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data.

  2007cited by this paper
• Propensity Scores in Cardiovascular Research

  2007cited by this paper
• Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.

  2007cited by this paper
• Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.

  2007cited by this paper
• Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.

  2006cited by this paper
• Differences between clinical trial efficacy and real-world effectiveness.

  2006cited by this paper
• Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.

  2006cited by this paper
• Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

  2006cited by this paper
• Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.

  2005cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Standards of Evidence: Criteria for Efficacy, Effectiveness and Dissemination

  2005cited by this paper
• Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum

  2004cited by this paper
• Risk stratification for sudden death: do we need anything more than ejection fraction?

  2003cited by this paper
• United States life tables, 2000.

  2002cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Interpretation and Classification of Microvolt T Wave Alternans Tests

  2002cited by this paper
• Book Review Paul Ehrlich's Receptor Immunology: The Magnificent Obsession By Arthur M. Silverstein. 202 pp., illustrated. San Diego, Calif., Academic Press, 2002. $75. 0-12-643765-3

  2002cited by this paper
• Estimating Causal Effects from Large Data Sets Using Propensity Scores

  1997cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.

  1997cited by this paper
• IMPROVED SURVIVAL WITH AN IMPLANTED DEFIBRILLATOR IN PATIENTS WITH CORONARY DISEASE AT HIGH RISK FOR VENTRICULAR ARRHYTHMIA

  1996cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

  1996cited by this paper
• Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

  1984cited by this paper
• Analysis of survival by tumor response.

  1983cited by this paper
• The central role of the propensity score in observational studies for causal effects

  1983cited by this paper
• Clinical Classification of Cardiac Deaths

  1982cited by this paper

• Regional differences in survival after ICD implantation

  2025cites this paper
• Efficacy and safety of implantable cardioverter-defibrillator implantation in the elderly—The I-70 Study: A randomized clinical trial

  2024cites this paper
• Defibrillator exchange in the elderly

  2023cites this paper
• Prevalence of One-Year Mortality after Implantable Cardioverter Defibrillator Placement: An Opportunity for Palliative Care?

  2022cites this paper
• Inter-American Society of Cardiology (CIFACAH-ELECTROSIAC) and Latin-American Heart Rhythm Society (LAHRS): multidisciplinary review on the appropriate use of implantable cardiodefibrillator in heart failure with reduced ejection fraction

  2022cites this paper
• Can Frailty Be a Predictor of ICD Shock after the Implantation of a Cardioverter Defibrillator in Elderly Patients?

  2021cites this paper
• Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.

  2021cites this paper
• Long-Term Survival in Patients with or without Implantable Cardioverter Defibrillator after Transcatheter Aortic Valve Implantation

  2021cites this paper
• Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults.

  2020cites this paper
• Decision‐making regarding primary prevention implantable cardioverter‐defibrillators among older adults

  2019cites this paper
• A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics

  2019cites this paper
• Ethical Conundra in CIED Therapy: Ethical Implantation, Ethical End-of-Life Care

  2019cites this paper
• Referral, Appropriateness and Eligibility of Implantable Cardioverter Defibrillator Therapy in Alberta

  2018cites this paper
• Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease

  2018cites this paper
• Quality of Life of Patients Over 80 Years Old with Implantable Cardioverter-Defibrillators

  2017cites this paper
• Long-term complications, reoperations and survival following cardioverter-defibrillator implant

  2017cites this paper
• The impact of co‐morbidity burden on appropriate implantable cardioverter defibrillator therapy and all‐cause mortality: insight from Danish nationwide clinical registers

  2017cites this paper
• The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality insight from Danish nationwide clinical registers Ruwald,

  2017cites this paper
• Improving the Methods for the Economic Evaluation of Medical Devices.

  2017cites this paper
• ICD for Patients With Severe Renal Dysfunction.

  2017cites this paper
• Patient-centred care of patients with ventricular arrhythmias and risk of sudden cardiac death: What do the 2015 European Society of Cardiology guidelines add?

  2017cites this paper
• Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure

  2017cites this paper
• [The management of ventricular arrhythmias in the elderly - are there differences?]

  2017cites this paper
• Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.

  2016cites this paper
• Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators Groupe de rythmologie et stimulation cardiaque de la Société française de cardiologie et Société française de gériatrie et gérontologie.

  2016cites this paper
• Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality

  2016influential citation
• Shocks, Resynchronization, or Both for Elderly Patients With Heart Failure?

  2016cites this paper
• 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2016cites this paper
• Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca

  2016cites this paper
• Increasing age does not affect time to appropriate therapy in primary prevention ICD/CRT‐D: a competing risks analysis

  2016cites this paper
• Ventricular high-rate episodes predict increased mortality in heart failure patients treated with cardiac resynchronization therapy

  2015cites this paper
• [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].

  2015cites this paper
• Safety : do elderly patients carry a higher risk of peri-and post-procedural complications ? Primum non nocere !

  2015cites this paper
• An Electrophysiologist Perspective on Risk Stratification in Heart Failure: Can Better Understanding of the Condition of the Cardiac Sympathetic Nervous System Help?

  2015cites this paper
• Acute Heart Failure Syndromes in the Elderly: The European Perspective.

  2015cites this paper
• Implantable Cardioverter-Defibrillator Use AmongMedicare PatientsWith Low Ejection Fraction After AcuteMyocardial Infarction

  2015influential citation
• Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations.

  2015cites this paper
• Prospective Use of Microvolt T-Wave Alternans Testing to Guide Primary Prevention Implantable Cardioverter Defibrillator Therapy.

  2015cites this paper
• Implantable Cardioverter–Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium

  2015cites this paper
• Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction.

  2015cites this paper
• Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure

  2015cites this paper
• Utilization, Outcomes and Costs of Implantable Cardioverter Defibrillators in Italy: A Population-Based Analysis Using Healthcare Administrative Databases.

  2014cites this paper
• Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials.

  2014cites this paper
• Intermediate-term mortality and incidence of ICD therapy in octogenarians after cardiac resynchronization therapy

  2014cites this paper
• Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups a systematic review.

  2014influential citation
• Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value.

  2014cites this paper
• Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.

  2014cites this paper
• Rates and reasons for device-based guideline eligibility in patients with heart failure.

  2014cites this paper
• Are we improving care of Medicare patients undergoing primary prevention implantable cardioverter-defibrillator implantation?

  2014cites this paper
• The Cost Effectiveness of Implantable Cardioverter Defibrillators: A Systematic Review of Economic Evaluations

  2014cites this paper
• Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death in Subgroups

  2014cites this paper
• Primary prevention defibrillators in clinical practice

  2014cites this paper
• Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly

  2013cites this paper
• Do elderly patients benefit from implantable defibrillators? "...in addition to meeting traditional eligibility criteria, the decision to implant an implantable cardioverter defibrillator in the elderly should also be individualized, focusing on comorbidities, projected quality of life and

  2013cites this paper
• Causes and prevention of sudden cardiac death in the elderly

  2013cites this paper
• Age-Related Differences in the Effect of Psychological Distress on Mortality: Type D Personality in Younger versus Older Patients with Cardiac Arrhythmias

  2013cites this paper
• Microvolt T wave alternans: Mechanisms and implications for prediction of sudden cardiac death

  2013cites this paper
• Do elderly patients benefit from implantable defibrillators

  2013cites this paper
• Age Differences in the Use of Implantable Cardioverter‐Defibrillators Among Older Patients Hospitalized with Heart Failure

  2013cites this paper
• Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death

  2013cites this paper
• Most Important Outcomes Research Papers on Device Therapies for Cardiomyopathies

  2013cites this paper
• Consideration of patient age and life expectancy in implantable cardioverter-defibrillator referral.

  2013cites this paper
• Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators.

  2013cites this paper
• A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification.

  2013cites this paper
• Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.

  2013cites this paper
• Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction: A Meta-analysis of Randomized Controlled Trials

  2013cites this paper
• Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death.

  2012cites this paper
• Ethics of the Heart: Ethical and Policy Challenges in the Treatment of Advanced Heart Failure

  2012cites this paper
• Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged ≥75 years versus those <75 years.

  2012cites this paper
• Longitudinal Study of Implantable Cardioverter-Defibrillators: Methods and Clinical Characteristics of Patients Receiving Implantable Cardioverter-Defibrillators for Primary Prevention in Contemporary Practice

  2012cites this paper
• Geographic Variation in Implantable Cardioverter-Defibrillator Use and Heart Failure Survival

  2012cites this paper
• Zastosowanie wszczepialnych kardiowerterów- -defibrylatorów w profilaktyce pierwotnej u pacjentów w podeszłym wieku. Systematyczny przegląd piśmiennictwa i metaanaliza

  2012cites this paper
• Cost-effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy

  2011cites this paper
• Influence of Age on Perioperative Complications Among Patients Undergoing Implantable Cardioverter-Defibrillators for Primary Prevention in the United States

  2011cites this paper
• Extent of and Reasons for Nonuse of Implantable Cardioverter Defibrillator Devices in Clinical Practice Among Eligible Patients With Left Ventricular Systolic Dysfunction

  2011cites this paper
• Landmark Analysis at the 25-Year Landmark Point

  2011cites this paper
• Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis.

  2011cites this paper
• Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Patients with Left Ventricular Systolic Dysfunction : 14 Years after

  2011cites this paper
• Low Referral Pattern for Implantable Defibrillator Therapy in a Tertiary Hospital: Referral Physician Survey and Monte Carlo Simulation

  2011cites this paper
• Age Differences in Primary Prevention Implantable Cardioverter‐Defibrillator Use in U.S. Individuals

  2011cites this paper
• Potential impact of optimal implementation of evidence-based heart failure therapies on mortality.

  2011cites this paper
• Ironic technology: Old age and the implantable cardioverter defibrillator in US health care.

  2011cites this paper
• [Update on geriatric cardiology].

  2011cites this paper
• Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.

  2011cites this paper
• Making longevity in an aging society: Linking technology, policy and ethics

  2011cites this paper
• The ECG: the old ally for a better selection of preventive ICD treatment?

  2011cites this paper
• Safety and Effectiveness of Primary Prevention Cardioverter defibrillators in Octogenarians

  2011cites this paper
• Defibrillator Implantation in the Elderly: Patients Are Older, But Are Physicians Wiser?

  2010cites this paper
• Implantable Cardioverter‐Defibrillators Confer Survival Benefit in Patients with Chronic Obstructive Pulmonary Disease

  2010cites this paper
• [The microvolt T-wave alternans test].

  2010cites this paper
• Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure

  2010cites this paper
• Fragmented QRS and Mortality Risk in Patients With Left Ventricular Dysfunction

  2010cites this paper
• Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?

  2010cites this paper
• Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease.

  2010cites this paper
• Device therapy for the management of cardiac tachyarrhythmias

  2010cites this paper
• Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.

  2010cites this paper
• Making Longevity in an Aging Society: Linking Medicare Policy and the New Ethical Field

  2010cites this paper
• Implantable Cardioverter-Defibrillator

  2010cites this paper
• Editor's Perspective Outcomes Research Myths and Realities

  2009cites this paper
• Outcomes research: myths and realities.

  2009cites this paper